Compare LGO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGO | OM |
|---|---|---|
| Founded | 1988 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.8M | 85.0M |
| IPO Year | 2007 | 2020 |
| Metric | LGO | OM |
|---|---|---|
| Price | $0.95 | $3.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $3.30 | ★ $16.00 |
| AVG Volume (30 Days) | 377.3K | ★ 504.6K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $111,884,000.00 | ★ $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | $53.91 | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.85 | $3.59 |
| 52 Week High | $2.70 | $25.35 |
| Indicator | LGO | OM |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 24.35 |
| Support Level | $0.88 | $3.66 |
| Resistance Level | $1.11 | $4.10 |
| Average True Range (ATR) | 0.07 | 0.33 |
| MACD | 0.00 | 0.24 |
| Stochastic Oscillator | 26.98 | 9.06 |
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.